Physician profile
Rabih I Bechara
NPI 1841240512
$453,423.54
in general payments reported to CMS, 2019-2025
38 companies · $86K in 2025
The $86K reported for 2025 was more than what 99% of Critical Care Medicine (Internal Medicine) providers received nationally (typical 2025 total: $189).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $48K · 2020: $12K · 2021: $2,426 · 2022: $96K · 2023: $139K · 2024: $69K · 2025: $86K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $219K · Travel and Lodging: $51K · Food and Beverage: $18K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,500 · Consulting Fee: $2,050.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $219,354.85 |
| Travel and Lodging | $51,215.50 |
| Food and Beverage | $17,992.68 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,500.00 |
| Consulting Fee | $2,050.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $383,677.07 | 2019-2025 | Da Vinci Surgical System, Da Vinci Sp |
| Astrazeneca Pharmaceuticals Lp | $33,218.45 | 2019-2020 | |
| Covidien Lp | $16,952.29 | 2019-2020 | |
| Pinnacle Biologics, INC | $5,197.23 | 2019-2023 | Photofrin |
| Olympus America INC. | $4,567.10 | 2019 | |
| Erbe Elektromedizin Gmbh | $2,588.00 | 2021-2022 | |
| Bard Peripheral Vascular, INC. | $1,763.38 | 2023 | |
| Cook Incorporated | $1,200.00 | 2019 | |
| Galvanize Therapeutics, INC | $824.35 | 2023-2025 | Aliya System |
| Ambu A/S | $590.00 | 2021 | |
| Pulmonx Corporation | $434.72 | 2019-2025 | Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Chartis Catheter |
| Spiration, INC. | $365.00 | 2019 | |
| Novartis Pharmaceuticals Corporation | $316.37 | 2019-2020 | |
| Cook Medical LLC | $189.82 | 2021-2025 | Hemospray |
| Genentech USA, INC. | $168.98 | 2019-2020 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Noah Medical Corporation | $167.64 | 2025 | Galaxy |
| Amgen INC. | $148.06 | 2019 | |
| Merck Sharp & Dohme LLC | $145.65 | 2019 | |
| Csa Medical, INC | $133.58 | 2019 | |
| Merit Medical Systems INC | $84.92 | 2024 | Aeromini Stent & Del Sys, Aero Stent and Delivery System |
| Erbe USA INC | $83.08 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $73.87 | 2019 | |
| Celgene Corporation | $66.29 | 2019 | |
| Ambu INC. | $56.33 | 2023 | |
| Inari Medical, INC. | $50.51 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $50.46 | 2019 | |
| Boston Scientific Corporation | $46.69 | 2023 | Spyglass |
| Janssen Biotech, INC. | $46.40 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $36.80 | 2019 | |
| Healthmyne, INC. | $35.45 | 2019 | |
| Ethicon INC. | $32.06 | 2020 | |
| Philips North America LLC | $28.66 | 2021 | |
| Sanofi-Aventis U.S. LLC | $22.14 | 2019 | |
| United Therapeutics Corporation | $21.80 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $14.58 | 2021 | |
| Inspire Medical Systems, INC. | $12.96 | 2023 | Inspire |
| Lilly USA, LLC | $12.85 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rabih Bechara listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.